Key result
Metabolic syndrome is associated with an increased risk of cardiovascular and non-cardiovascular diseases, highlighting the importance of prevention, early diagnosis, and multifactorial treatment.
Metabolic syndrome is a cluster of risk factors associated with increased cardiovascular, metabolic, and non-cardiovascular morbidity, highlighting the need for early diagnosis and multifactorial treatment.
The term metabolic syndrome (MeS) refers to a cluster of associated symptoms composed of impaired fasting glucose, abdominal obesity, hypertension, and dyslipidemia. MeS is associated with an increased risk of cardiovascular and diabetes-associated morbidity and mortality. The increased amount of visceral fat together with a chronic inflammatory state predisposes to the development of arteriosclerosis. Furthermore, insulin resistance (IR) and dyslipidemia are associated with fatty liver disease. In addition, MeS is linked to non-cardiovascular diseases such as cancer as well as psychiatric or endocrine disorders. Here, we discuss the clinical impact of MeS in cardiovascular and non-cardiovascular diseases to highlight the importance of prevention, early diagnosis, and multifactorial treatment of high-risk individuals.
No takes yet. Share an insight, caveat, or question.
Brede et al. (2016) conducted a review in Metabolic syndrome. Metabolic syndrome was evaluated. Metabolic syndrome is associated with an increased risk of cardiovascular and non-cardiovascular diseases, highlighting the importance of prevention, early diagnosis, and multifactorial treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: